Medartis Holding AG (XSWX:MED) Selling, General, & Admin. Expense: CHF172.7 Mil (TTM As of Dec. 2025)


XSWX:MED Medartis Holding AG XSWX:MED
86 GF Score
Price CHF91.20
GF Value CHF107.02
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Medartis Holding AG Selling, General, & Admin. Expense?

Medartis Holding AG XSWX:MED -0.55% 86 Selling, General, & Admin. Expense is CHF172.7 Mil as of Dec. 2025. GuruFocus rates XSWX:MED with a GF Score™ of 86/100 and a GF Value™ of CHF107.02 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Selling, general, & admin. expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. Medartis Holding AG's selling, general, & admin. expense for the six months ended in Dec. 2025 was CHF96.8 Mil. Its selling, general, & admin. expense for the trailing twelve months (TTM) ended in Dec. 2025 was CHF172.7 Mil.


Medartis Holding AG  (XSWX:MED) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.


Medartis Holding AG Selling, General, & Admin. Expense Related Terms


Medartis Holding AG Selling, General, & Admin. Expense Historical Data

* Premium members only.

The historical data trend for Medartis Holding AG's Selling, General, & Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medartis Holding AG Selling, General, & Admin. Expense Chart

Medartis Holding AG Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Selling, General, & Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 103.05 126.03 131.99 140.51 172.72

Medartis Holding AG Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Selling, General, & Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 68.46 71.69 68.82 75.93 96.79

XSWX:MED vs ABT, SYK, MDT: Selling, General, & Admin. Expense Comparison

For the Medical Devices subindustry, Medartis Holding AG's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medartis Holding AG Selling, General, & Admin. Expense vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medartis Holding AG's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Medartis Holding AG's Selling, General, & Admin. Expense falls into.


XSWX:MED
86GF Score
Medartis Holding AG XSWX:MED
Selling, General, & Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medartis Holding AG Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF172.7 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Selling, General, & Admin. Expense of CHF172.7 Mil mean?
Medartis Holding AG (XSWX:MED) has a Selling, General, & Admin. Expense of CHF172.7 Mil as of Dec. 2025. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Medartis Holding AG and its competitors.
Is Medartis Holding AG's Selling, General, & Admin. Expense too high?
Medartis Holding AG's current Selling, General, & Admin. Expense is CHF172.7 Mil. Overall, Medartis Holding AG has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medartis Holding AG's Selling, General, & Admin. Expense compare to ABT and SYK?
Medartis Holding AG's Selling, General, & Admin. Expense of CHF172.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Selling, General, & Admin. Expense for a Medical Devices & Instruments company?
A good Selling, General, & Admin. Expense depends on the Medical Devices & Instruments industry context. However, Selling, General, & Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Selling, General, & Admin. Expense mean?
A high Selling, General, & Admin. Expense can signal that a stock is expensive relative to its fundamentals. Selling, general and admin expense is the total cost for direct, indirect, general and administrative activities. View historical data on Medartis Holding AG and its competitors. Medartis Holding AG's current Selling, General, & Admin. Expense is CHF172.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medartis Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Medartis Holding AG (XSWX:MED) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF107.02, compared to a current price of CHF91.20 — trading 14.8% below its estimated fair value. The current Selling, General, & Admin. Expense is CHF172.7 Mil. Medartis Holding AG's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Selling, General, & Admin. Expense calculated?
Selling, General, & Admin. Expense is calculated from a company's financial statements. For Medartis Holding AG (XSWX:MED), the current Selling, General, & Admin. Expense is CHF172.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medartis Holding AG (XSWX:MED) Overvalued in 2026?

Based on GuruFocus' analysis, Medartis Holding AG stock appears to be undervalued. The current stock price of CHF91.20 is trading 14.8% below its estimated GF Value™ of CHF107.02. GuruFocus considers Medartis Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:MED:

  • Selling, General, & Admin. Expense: CHF172.7 Mil
  • GF Value™: CHF107.02 vs. price of CHF91.20 (14.8% below fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the XSWX:MED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medartis Holding AG Business Description

Other Exchanges MEDz:UK1RU:Germany
Address Hochbergerstrasse 60E, Basel, CHE, 4057
Medartis Holding AG is a medical device company. The company's product profile is divided into APTUS products, StealthFix Products, and MODUS products. APTUS includes products for the Hand, Wrist, Elbow, Shoulder, and Foot. MODUS comprises products for the mandible. Geographically, it derives the majority of its revenue from Europe, Middle East and Africa (EMEA) and also has a presence in North America, Asia Pacific, and Latin America.
86GF Score

Get the complete analysis for XSWX:MED

Selling, General, & Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF91.20
Price
CHF107.02
GF Value